EMA — authorised 17 March 2011
- Marketing authorisation holder: Sanofi Winthrop Industrie
- Status: approved
EMA authorised Jevtana Kit on 17 March 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 17 March 2011.
Sanofi Winthrop Industrie holds the EU marketing authorisation.